Prime Medicine

IPO

Delivering on the promise of Prime Editing

Public · Cambridge, United States · Founded 2019 · $339.0M raised

Employees
201–500
Founded
2019
Business Model
B2B
Total Funding
$339.0M
Last Round
$24.0M GrantJul 2025
Rounds
3
Type
Public

About

Prime Medicine develops next-generation gene therapies using its proprietary Prime Editing platform, which can search and replace disease-causing genetic sequences without causing double-strand DNA breaks. Founded in 2019 based on technology from the Broad Institute, the company focuses on liver, lung, immunology, and oncology indications. It has a strategic collaboration with Bristol Myers Squibb and is advancing programs toward IND filings.

Summary

Prime Medicine is a Biotech company based in Cambridge, United States, founded in 2019. It has raised $339.0M in total across 3 rounds, most recently a $24.0M Grant round in Jul 2025. Investors include Newpath Management, Cystic Fibrosis Foundation and ARCH Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantJul 2025
$24.0M

Sign up to see all 3 rounds

Series B through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prime Medicine on Indexed.vc
<a href="https://indexed.vc/companies/prime-medicine"><img src="https://indexed.vc/api/badge/company/prime-medicine" alt="Prime Medicine on Indexed.vc" width="260" height="76" /></a>